Home/Pipeline/CRISPR-BMC Genome Editing

CRISPR-BMC Genome Editing

Development of high-performance microbial production strains

Platform Technology / R&DActive

Key Facts

Indication
Development of high-performance microbial production strains
Phase
Platform Technology / R&D
Status
Active
Company

About Brain Biotech

BRAIN Biotech AG is a technology and service provider focused on industrial biotechnology, operating as a publicly traded company on the Frankfurt Stock Exchange. Its mission is to create a #BiobasedFuture by providing customized research and development solutions for clients facing scientific challenges in enzyme, protein, and microorganism development. The company's value proposition centers on saving clients time and resources, driving innovation, offering flexibility, and reducing project risk through its advanced technology portfolio and multi-disciplinary expertise. Its strategic direction involves scaling its proprietary platforms, such as its methanol-free Komagataella phaffii protein production system, to serve the growing demand for sustainable industrial bioprocesses.

View full company profile